Laustsen, C., Lycke, S., Palm, F.
, Østergaard, J., Bibby, B. M., Nørregaard, R., Flyvbjerg, A., Pedersen, M. & Ardenkjær-Larsen, J. H. (2013).
RENAL METABOLISM DURING ALTERED OXYGEN AVAILABILITY, ASSESSED WITH HYPERPOLARIZED [1-13C]PYRUVATE. Abstract from 4th International DNP Symposium, Elsinore, Denmark.
Lindberg, S., Mogelvang, R., Pedersen, S. H.
, Bjerre, M., Frystyk, J., Flyvbjerg, A., Galatius, S. & Jensen, J. S. (2013).
Relation of Serum Adiponectin Levels to Number of Traditional Atherosclerotic Risk Factors and All-Cause Mortality and Major Adverse Cardiovascular Events (from the Copenhagen City Heart Study).
American Journal of Cardiology,
111(8), 1139-45.
https://doi.org/10.1016/j.amjcard.2012.12.043
Løgstrup, B. B., Høfsten, D. E., Christophersen, T. B., Møller, J. E.
, Bjerre, M., Flyvbjerg, A., Bøtker, H. E. & Egstrup, K. (2013).
Microvascular dysfunction is associated with plasma osteoprotegerin levels in patients with acute myocardial infarction.
Coronary Artery Disease.
https://doi.org/10.1097/MCA.0b013e328363242e
Mackenhauer, J., Møller, M. C. M., Fjældstad, A., Østervig1, R., Al ¤Kole1, A., Folkestad, L., Hallas, P., Brabrand, M.
, Moellekaer, A. & Kirkegaard, H. (2013).
Speciallægen er ikke i front på de danske akutafdelinger (The use of consultants in the Emergency Department).
Ugeskrift for Læger,
175(8), 491-494.
Madsen, M., Fisker, S., Feldt-Rasmussen, U., Andreassen, M., Kristensen, L. Ø.
, Orskov, H. & Jørgensen, J. O. L. (2013).
Circulating levels of pegvisomant and endogenous GH during prolonged pegvisomant therapy in patients with acromegaly.
Clinical Endocrinology,
80(1), 92-100.
https://doi.org/10.1111/cen.12239
Mehrparvar, A. H., Davari, M. H., Mollasadeghi, A., Vahidi, M. R., Mostaghaci, M., Bahaloo, M.
& Shokouh, P. (2013).
Hearing Loss due to Carbon Monoxide Poisoning.
Case Reports in Otolaryngology,
2013, 940187.
https://doi.org/10.1155/2013/940187
Meinhardt, U.
, Christiansen, J. S., Farholt, S., Lämmer, C.
, Ostergaard, J. R., Schmidt, F., Kappelgaard, A.-M. & Eiholzer, U. (2013).
The Efficacy and Safety of Long-term Norditropin® Treatment in Children with Prader-Willi Syndrome.
Hormone and Metabolic Research.
https://doi.org/10.1055/s-0033-1343449